199 related articles for article (PubMed ID: 10482644)
1. Requirement for cell-to-cell contact in Epstein-Barr virus infection of nasopharyngeal carcinoma cells and keratinocytes.
Chang Y; Tung CH; Huang YT; Lu J; Chen JY; Tsai CH
J Virol; 1999 Oct; 73(10):8857-66. PubMed ID: 10482644
[TBL] [Abstract][Full Text] [Related]
2. Detection of transcripts initiated from two viral promoters (Cp and Wp) in Epstein-Barr virus-infected nasopharyngeal carcinoma cells and biopsies.
Chang Y; Sheen TS; Lu J; Huang YT; Chen JY; Yang CS; Tsai CH
Lab Invest; 1998 Jun; 78(6):715-26. PubMed ID: 9645762
[TBL] [Abstract][Full Text] [Related]
3. The mechanism of Epstein-Barr virus infection in nasopharyngeal carcinoma cells.
Lin CT; Lin CR; Tan GK; Chen W; Dee AN; Chan WY
Am J Pathol; 1997 May; 150(5):1745-56. PubMed ID: 9137098
[TBL] [Abstract][Full Text] [Related]
4. [Epstein-Barr virus infection in the pathogenesis of nasopharyngeal carcinoma].
Niedobitek G
Pathologe; 1998 Sep; 19(5):337-44. PubMed ID: 9816588
[TBL] [Abstract][Full Text] [Related]
5. Epstein-Barr virus in nasopharyngeal carcinoma in Indian patients.
Rathaur RG; Chitale AR; Banerjee K
Indian J Cancer; 1999; 36(2-4):80-90. PubMed ID: 10921211
[TBL] [Abstract][Full Text] [Related]
6. Epstein-Barr virus infection to Epstein-Barr virus-negative nasopharyngeal carcinoma cell line TW03 enhances its tumorigenicity.
Teramoto N; Maeda A; Kobayashi K; Hayashi K; Oka T; Takahashi K; Takada K; Klein G; Akagi T
Lab Invest; 2000 Mar; 80(3):303-12. PubMed ID: 10744066
[TBL] [Abstract][Full Text] [Related]
7. A new lytic antibody, 7D6, detects Epstein-Barr virus dUTPase in nonkeratinizing undifferentiated nasopharyngeal carcinomas.
Nicholls JM; Sommer P; Kremmer E; Ong KS; Fung K; Lee JM; Ng MH; Grässer FA
Lab Invest; 1998 Aug; 78(8):1031-2. PubMed ID: 9714190
[No Abstract] [Full Text] [Related]
8. In vitro production of stable Epstein-Barr virus-positive epithelial cell clones which resemble the virus:cell interaction observed in nasopharyngeal carcinoma.
Knox PG; Li QX; Rickinson AB; Young LS
Virology; 1996 Jan; 215(1):40-50. PubMed ID: 8553585
[TBL] [Abstract][Full Text] [Related]
9. Synergistic effect of Epstein-Barr virus and tumor promoters on induction of lymphoma and carcinoma in nude mice.
Liu Z; Liu Y; Zeng Y
J Cancer Res Clin Oncol; 1998; 124(10):541-8. PubMed ID: 9829857
[TBL] [Abstract][Full Text] [Related]
10. Comparative analysis of Epstein-Barr virus (EBV) detection by nested-PCR and non-isotopic in situ hybridization in nasopharyngeal carcinoma (NPC).
Vera-Sempere F; Burgos J; Botella MS; Morera C
Clin Chim Acta; 1998 Mar; 271(2):119-32. PubMed ID: 9565328
[TBL] [Abstract][Full Text] [Related]
11. Expression of Epstein-Barr virus-encoded RNAs as a marker for metastatic undifferentiated nasopharyngeal carcinoma.
Chao TY; Chow KC; Chang JY; Wang CC; Tsao TY; Harn HJ; Chi KH
Cancer; 1996 Jul; 78(1):24-9. PubMed ID: 8646721
[TBL] [Abstract][Full Text] [Related]
12. NF-κB Signaling Regulates Expression of Epstein-Barr Virus BART MicroRNAs and Long Noncoding RNAs in Nasopharyngeal Carcinoma.
Verhoeven RJ; Tong S; Zhang G; Zong J; Chen Y; Jin DY; Chen MR; Pan J; Chen H
J Virol; 2016 Jul; 90(14):6475-88. PubMed ID: 27147748
[TBL] [Abstract][Full Text] [Related]
13. Clonal proliferations of cells infected with Epstein-Barr virus in preinvasive lesions related to nasopharyngeal carcinoma.
Pathmanathan R; Prasad U; Sadler R; Flynn K; Raab-Traub N
N Engl J Med; 1995 Sep; 333(11):693-8. PubMed ID: 7637746
[TBL] [Abstract][Full Text] [Related]
14. Prognostic value of anti-Epstein-Barr virus antibodies in nasopharyngeal carcinoma (NPC).
Liu MT; Yeh CY
Radiat Med; 1998; 16(2):113-7. PubMed ID: 9650898
[TBL] [Abstract][Full Text] [Related]
15. Epstein-Barr virus infection and nasopharyngeal carcinoma.
Tsao SW; Tsang CM; Lo KW
Philos Trans R Soc Lond B Biol Sci; 2017 Oct; 372(1732):. PubMed ID: 28893937
[TBL] [Abstract][Full Text] [Related]
16. Nasal and nasal-type T/NK cell lymphoma: a unique form of lymphoma associated with the Epstein-Barr virus.
Jaffe ES
Histopathology; 1995 Dec; 27(6):581-3. PubMed ID: 8838342
[No Abstract] [Full Text] [Related]
17. Activation of lytic cycle of Epstein-Barr virus by suberoylanilide hydroxamic acid leads to apoptosis and tumor growth suppression of nasopharyngeal carcinoma.
Hui KF; Ho DN; Tsang CM; Middeldorp JM; Tsao GS; Chiang AK
Int J Cancer; 2012 Oct; 131(8):1930-40. PubMed ID: 22261816
[TBL] [Abstract][Full Text] [Related]
18. EBV Infection and Glucose Metabolism in Nasopharyngeal Carcinoma.
Zhang J; Jia L; Tsang CM; Tsao SW
Adv Exp Med Biol; 2017; 1018():75-90. PubMed ID: 29052133
[TBL] [Abstract][Full Text] [Related]
19. Epstein-Barr virus mRNA profiles and viral DNA methylation status in nasopharyngeal brushings from nasopharyngeal carcinoma patients reflect tumor origin.
Ramayanti O; Juwana H; Verkuijlen SA; Adham M; Pegtel MD; Greijer AE; Middeldorp JM
Int J Cancer; 2017 Jan; 140(1):149-162. PubMed ID: 27600027
[TBL] [Abstract][Full Text] [Related]
20. Detection of Epstein-Barr virus genome in nasopharyngeal carcinoma by in situ DNA hybridization.
Chen CL; Wen WN; Chen JY; Hsu MM; Hsu HC
Intervirology; 1993; 36(2):91-8. PubMed ID: 8294187
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
